NovoCure Ltd News - NVCR | ADVFN

Register to chat with like-minded investors on our interactive forums.

Get Started

NovoCure Ltd (NVCR)

12.05

0.00

(0.00%)

Closed April 18 4:00PM

Delayed by 15 minutes

12.04

0.00

(0.00%)

After Hours: 7:53PM

Delayed by 15 minutes

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

Novocure (NASDAQ: NVCR) today announced 20 presentations on Tumor Treating Fields (TTFields) therapy will be delivered at the American...

Novocure to Report First Quarter 2024 Financial Results

Novocure (NASDAQ: NVCR) announced today that it will report financial results for the first quarter 2024 on Thursday, May 2, 2024, before the...

METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長

METIS臨床試験では、脳腫瘍に対する腫瘍治療電場療法（Tumor Treating Field）と支持療法を併用した患者の頭蓋内進行までの期間中央値が21.9カ月であったの...

Klinische Phase-3-Studie METIS erreicht primären Endpunkt und zeigt eine statistisch signifikante Verlängerung der Zeit bis zur intrakraniellen Progression bei Patient:innen mit Hirnmetastasen von nicht-kleinzelligem Lungenkrebs

Die METIS-Studie zeigte eine mediane Zeitspanne von 21,9 Monaten bis zur intrakraniellen Progression bei Patienten, die mit Tumor Treating Fields...

L’essai clinique de phase 3 METIS a atteint son critère principal, démontrant un allongement statistiquement significatif du délai médian jusqu’à la progression intracrânienne chez les patients porteurs de métastases cérébrales consécutives..

L’essai METIS a montré que le délai médian avant progression intracrânienne était de 21,9 mois chez les patients traités avec la thérapie Tumor...

METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

The METIS trial demonstrated 21.9 months median time to intracranial progression for patients treated with Tumor Treating Fields and supportive...

INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO

Exploratory subgroup analysis from INNOVATE-3 finds that pegylated liposomal doxorubicin (PLD) -naïve patients randomized to receive TTFields...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

1
Next

KIPK

KIPK 2 weeks ago

20? including a PRE-CLINICAL???? lol
And all that unfocused activity signal the total desperation to keep the SP up IMO...

Reminds me of INO, which also kept throwing stuff at every possible thing, hoping one would stick.... But NO... INO SP at one time was over $2000 & now is around $11 after a recent RS

axelvento

axelvento 2 weeks ago

Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

https://www.biospace.com/article/releases/novocure-announces-20-presentations-on-tumor-treating-fields-highlighting-preclinical-effects-in-pancreatic-cancer-and-immune-effects-at-american-association-for-cancer-research-aacr-annual-meeting-2024/

TiltMyBrain

TiltMyBrain 2 weeks ago

#dcvax $nwbo #gbm

Washinton State's HCA has denied coverage for Tumor Treating Fields, preventing access to this treatment option for Washington Medicaid patients and state employees.

'Optune/Tumor Treating Fields (TTF):
Petition for rereview received. Not selected for… pic.twitter.com/OPPsTyjXhk— Peter Davis (@peter_brit) April 2, 2024

This ship is sinking fast!

👍️ 1 👏 1

TiltMyBrain

TiltMyBrain 3 weeks ago

insider selling in 3...2...1...

👍️ 1 💯 1 😂 1 🤣 1

TiltMyBrain

TiltMyBrain 3 weeks ago

"Preliminary analyses of key secondary endpoints (time to neurocognitive failure, overall survival, and radiological response rate) did not demonstrate statistical significance."

pump and dump in progress

👍️ 1 💯 1 🤡 1 🤣 1

whosleftholdindabag

whosleftholdindabag 3 weeks ago

Loving the early action on $NVCR. Wishing everybody a great day! GLTA

🗑️ 1 🤣 1

KIPK

KIPK 3 weeks ago

LOL - "In time to Intracranial Progression" ??? SMH

Awl416

Awl416 3 weeks ago

METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

👍️ 2 💯 1

KIPK

KIPK 3 weeks ago

The Vanishing tin can on the wind of ineffectiveness!!
Have a kick at it MATE - LOL !!

KIPK

KIPK 4 weeks ago

You just made a positive post for NWBO without knowing it MATE. Think JAMA.....

And that's So sad as You must be in total loss for words to be citing here a post by a Paid NWBO Basher, InquiriNg. At least you should have given the credit as she, just like you, has been lost for words as well MATE!! . LOL Mate!!

You Birt got nothing & the tin hat is made for a tin man... just like you & the charity investor scamwannabe!!
LOL

👍️ 2 💩 1 🖕 1 🤣 1

jondoeuk

jondoeuk 4 weeks ago

NWBO's DCVax-L is an expensive placebo. The same is true for DCVax-Direct.

👍️ 1 💯 1 🗑️ 1 🤮 1

KIPK

KIPK 1 month ago

Congrats whosbagholding. You keep expanding your reach into Charity Work. LOL - SMH...

Below is a response to one of your good will intention (LOL) on NWBO MB>>>>
Re: AAPL31415926 post# 679357

Monday, March 18, 2024 8:40:02 AM

Post#
679360
of 679363
Amazing that whosbagholding gave me a clown emoji on this comment. It shows how absolutely evil these people are. Hopefully he/she/it/they don't have to face their spouse or one of their children being diagnosed with a fatal disease that they work hard to try and destroy a cure for. Then again there's always karma.

KIPK

KIPK 1 month ago

Who S Left Hold In D Bag - LOL LOL LOL LOL - Brit Mate?? LOL

👍️ 1 💩 1 🖕 1 🤣 1

KIPK

KIPK 1 month ago

Anyone looking for, whosleftholdindabag, the fake charity worker mate (lol), he spends all his time on NWBO MB, fingering up 🖕🏻 (LOL), NWBO paid bashers.
This dude is full of undigested charity food (LOL)

👍️ 1 💥 1 💩 1 🖕 1 😂 1 🤣 1

KIPK

KIPK 2 months ago

whosleftholdindabag - LOL, LOL, LOL< LOL👎🏻🤢

👍️ 1 💥 1

KIPK

KIPK 2 months ago

whosleftholdindabag - This thing must TOTALLY Believe Survival of NVCR, that he claims invested in for charity, TOTALLY Depends on Death of NWBO, Otherwise why Spending all hours on NWBO MB, supporting NWBO Bashers, while giving 👎🏻 / 🤡 to NWBO Longs???

A charitable character would innately support all companies who are trying to do good & and be a positive difference maker in peoples life! I guess that description is contrary to his motives!!

👍️ 2 💯 1

KIPK

KIPK 2 months ago

Poor resentful LOSER....
Rent Free, LOL... I just hate pretenders like you ... MATE?? LOL///
Like lurking Junk yard dog.... as you are..
Bloody Bitter?? who uses that term... ??
Dummy Englishio??
Woof Woof Woof...
Bugger off??? LOL --- How old are you? 100? LOL

👍️ 2 🤣 1

whosleftholdindabag

whosleftholdindabag 2 months ago

Why are you so bloody bitter mate? I live rent-free in your head, find a hobby, get a job, and do something useful with your life!

It's a shame about Dr. B. I thought he was a good bloke.

Go back to your other obsession, $NWBO and bugger off!

👍️ 1 💩 1 🤢 1

KIPK

KIPK 2 months ago

Hey, whosleftholdindabag. Who is Holding That Big, Fat, Bag?? The Fake Tech is declaring its Fakeness IMO...
Keep adding now!!

👍️ 1 🤣 1

KIPK

KIPK 2 months ago

Fake charity investor, whosleftholdindabag, keep lucking around NWBO MB, giving thumbs up to known trash or cash posters & thumbs down to reputable/knowledgeable NWBO investors..

What a waste of a life... SMH

👍️ 1 💩 1 💯 1 🖕 1

dennisdave

dennisdave 2 months ago

sure click on the link https://investorshub.advfn.com/boards/replies.aspx?msg=173765065
take the mouse from your mom's computer and move the mouse pointer on your screen (so not the actual mouse in your hand but the one on the screen) to the link (the link is in blue in the post). Click the right button on the mouse in your hand to open the link. Then reread the post. If you dont understand these instructions ask a caregiver to help you.

KIPK

KIPK 3 months ago

Its so, so, so incredible therapy that its MB see all read/// LOL

KIPK

KIPK 3 months ago

The poor & Desperate, whosleftholdindabag, spends all his time giving thumbs up supports to any who posts something negative about NWBO, SMH...

What a pretend BS...

KIPK

KIPK 3 months ago

whoseletholdingabag... LOL.. & LOL big time at you... NVCR is stuck here until it goes to sub1$

KIPK

KIPK 3 months ago

bottomless pit because the stuff doesn't work as advertised IMO

KIPK

KIPK 3 months ago

NOoooo, junkoeuk,,,, The NoCure Signals were twisted from the get go.... game over now that the cat out of the hat finally IMO... da update, da rev. no matter what you post... Fact has this down from over 200 to about $10,,, dat should tell you some fact!! LOLing,,,,

👍️ 1 💯 1

jondoeuk

jondoeuk 3 months ago

TRIDENT update https://www.businesswire.com/news/home/20240109397768/en/Novocure-Announces-Last-Patient-Enrolled-in-Phase-3-TRIDENT-Trial-in-Newly-Diagnosed-Glioblastoma

jondoeuk

jondoeuk 3 months ago

Full Year and Fourth Quarter '23 Net Revenues and Company Update https://finance.yahoo.com/news/novocure-announces-preliminary-full-fourth-120000184.html

👍️ 1 👎🏻 1

KIPK

KIPK 3 months ago

NoCure Trapping More INVESTORS IMO.. This thing not worth considering at all IMO,,,
A treading stock for those skilled to do it IMO..

jondoeuk

jondoeuk 3 months ago

Upcoming https://www.biospace.com/article/releases/novocure-to-participate-in-42nd-annual-j-p-morgan-healthcare-conference/

👍️ 1 👎🏻 1

dstock07734

dstock07734 4 months ago

He used to be silent. At most, he just liked some of the posts by his minions to remind them: Big brother is watching.

The fact he broke silence all of sudden shows how desperate he is now with the latest PR from NWBO. 2024 is not going to be lovely for him.

👍️ 1 💥 1

KIPK

KIPK 4 months ago

Fake Charity Contributor. Keep Bashing NWBO!! LOL. what nobody!!

KIPK

KIPK 4 months ago

And the Charity Bag-holder sounds BLOODY BRITSH .. LOL, you “IS” truly A BLOODY LOSER.
Go get some crisp in used newspapers rapping!!!
Lol

👍️ 1 💥 1

KIPK

KIPK 4 months ago

Whosleleftholeindabag. You must be the worse manipulator as a charity investor. A charitable being does NOT go to other company MB & posts trash, hoping that company, NWBO, would fail, so that NVCR, you keep claiming you invested in for charity, would win!!

Dude, you are the worst among the manipulating worst I have encounter.
Just think KARMA.

What a loser.. LOL!!

👍️ 1 💥 1

whosleftholdindabag

whosleftholdindabag 4 months ago

A lovely way to close out 2023! Go $NVCR we're going to raise a lot of money for charity! GLTA

TiltMyBrain

TiltMyBrain 4 months ago

Desperation for sure

KIPK

KIPK 4 months ago

And NoCure is firing staff. Then this loser claiming he is adding AGAIN & AGAIN & AGAIN...

Delusional? or Manipulator?

👍️ 3 💩 1 🖕 1

TiltMyBrain

TiltMyBrain 4 months ago

Northwest Bio files for mhra approval

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-a-marketing-authorization-application-has-been-submitted-to-the-uk-mhra-for-dcvax-l-for-glioblastoma-302021038.html

NVCR is toast!

👍️ 4 💥 3 🤡 2

whosleftholdindabag

whosleftholdindabag 5 months ago

Another 25k share purchase $NVCR. The company is serious about controlling costs! Probably my last purchase this year. GLTA

💩 2 🖕🏻 2 🤡 1

TiltMyBrain

TiltMyBrain 5 months ago

This ship is sinking fast!

KIPK

KIPK 5 months ago

On this thanksgiving day, Whosleftholdindabag, the Self Proclaimed Charity Investor, spending his charity day
supporting the well know NWBO paid basher LC2020......

Dude you have set a very high standards for yourself!!! LOL

KAMA looking you in the EYE!!!!

👍️ 1 🖕🏻 1 🤮 1

KIPK

KIPK 5 months ago

whosleftholdindabag is Left Giving Thumbs Down to NWBO investors on its MB... What a fake charity supporting loser!!

KARMA looking into your EYE!!

KIPK

KIPK 5 months ago

Its time for a bigger bag for whoslefthHOLDINGdaBG...... Bag holder!! go to it now!!

LOL

dstock07734

dstock07734 5 months ago

Please read the two posters from Dr. Liau. Then you probably have a good idea on the significance of TCR sequencing. You probably also understand why Merck had collaboration with those Next Generation Sequencing companies as early as 2015.

👍️ 1 💥 1

dstock07734

dstock07734 5 months ago

Is it so hard to embrace the future? NVCR is sinking and you know it.

Here is the future.

https://academic.oup.com/neuro-oncology/article-abstract/25/Supplement_5/v64/7405465?redirectedFrom=fulltext#no-access-message

T CELL RESPONSE DYNAMICS IN PHASE 3 GLIOBLASTOMA PATIENTS IMMUNIZED WITH AUTOLOGOUS DENDRITIC CELLS PULSED WITH AUTOLOGOUS TUMOR CELL LYSATE

BACKGROUND

331 glioblastoma patients were immunized with autologous dendritic cells (DCs) pulsed with autologous tumor cell lysate or placebo in a Phase 3 clinical trial. Immunization with the pulsed DCs was associated with extended overall survival in both newly diagnosed and recurrent disease. Objective: To characterize T cell responses and T cell response dynamics in patients immunized with autologous dendritic cells pulsed with autologous tumor cell lysate.

METHODS

we performed T cell receptor sequencing on peripheral blood mononuclear cells from both newly diagnosed and recurrent glioblastoma patients that were treated with the pulsed DCs. Timepoints from both before and after immunization were compared to understand T cell response dynamics.

RESULTS

Expansion of several hundred new T cell clones as well as more than 700 previously detected T cell clones was detected over time in both newly diagnosed and recurrent GBM patients who were treated with the pulsed DCs. Investigation of the dynamics of the response demonstrated that further expansion was triggered by ongoing immunizations. Correlations between T cell response data and clinical outcomes are ongoing.

CONCLUSION

Immunization with autologous DCs pulsed with autologous tumor cell lysate induces broad spectrum immune responses in patients with glioblastoma.

👍️ 1 💥 1

jondoeuk

jondoeuk 5 months ago

The abstracts

https://jitc.bmj.com/content/11/Suppl_1/A661

https://jitc.bmj.com/content/11/Suppl_1/A691

https://jitc.bmj.com/content/11/Suppl_1/A1189

💩 1 🖕🏻 1

TiltMyBrain

TiltMyBrain 5 months ago

Single digits on the way

Garyedward71

Garyedward71 5 months ago

Or they know something we already know.

TiltMyBrain

TiltMyBrain 5 months ago

And the insiders continue to sell. They hate the shareholders

whosleftholdindabag

whosleftholdindabag 6 months ago

One more purchase 27.5k shares of $NVCR to finish off the year! GLTA

💩 1 🤡 1 🤮 1

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions